DIPROSPAN

This brand name is authorized in Brazil, Ecuador, Estonia, Hong Kong SAR China, Israel, Mexico, Singapore, Turkey.

Active ingredients

The drug DIPROSPAN contains a combination of these active pharmaceutical ingredients (APIs):

1	Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone
2	Betamethasone UNII 7BK02SCL3W - BETAMETHASONE SODIUM PHOSPHATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB01	Betamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	540917030027117, 540917030027217
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.672-10-05
EE	Ravimiamet	1764468
HK	Department of Health Drug Office	18689
IL	מִשְׂרַד הַבְּרִיאוּת	1252, 4634
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	87216
SG	Health Sciences Authority	04759P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636750278